Biotech, Food & Drug

HB Ad Slot
HB Mobile Ad Slot

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotechnology, Food & Drug Administration FDA News

Title
Publication Date Organization
Aug
22
2017
USDA-FSIS Issues Updated Guidelines for Premarket Label Approval Keller and Heckman LLP
Aug
21
2017
Food Identity Disputes Continue to Impose High-Profile Pressure on FDA Mintz
Aug
21
2017
OIE Publishes Report on Global Antimicrobial Use Keller and Heckman LLP
Aug
21
2017
Athena Diagnostics, Inc. v. Mayo (D. Mass., August 4, 2017) – “That’s all,” She Wrote. Schwegman, Lundberg & Woessner, P.A.
Aug
21
2017
EpiPen Maker Mylan Gets Stuck With $465 Million Fine; Politicians Say it Doesn’t Sting Enough Cadwalader, Wickersham & Taft LLP
Aug
18
2017
Japan Finalizes Report on Positive List System for Food-Contact Materials Keller and Heckman LLP
Aug
18
2017
EPA Releases Final Guidance on TSCA Section 8(a) Nanomaterial Reporting Rule Beveridge & Diamond PC
Aug
18
2017
U.S. Pork Regains Entry to Argentina for First Time Since 1992 Keller and Heckman LLP
Aug
18
2017
Biofuel Industry Testifies At EPA Hearing On RFS Program Bergeson & Campbell, P.C.
Aug
18
2017
DOC Postpones Biodiesel AD/CVD Investigation Preliminary Determinations Bergeson & Campbell, P.C.
Aug
18
2017
EIA Publishes May Biodiesel Production Report Bergeson & Campbell, P.C.
Aug
18
2017
FDA Makes Moves to Advance Digital Health Epstein Becker & Green, P.C.
Aug
18
2017
NIOSH Report Highlighting Second Decade of Research Agenda Includes Nano Developments Bergeson & Campbell, P.C.
Aug
17
2017
High Time for Massachusetts Employers to Consider a Marijuana Use Policy Murtha Cullina
Aug
17
2017
Scrambling After an Egg Crisis – EU Safety Guidance for Online Product Sales Sheppard, Mullin, Richter & Hampton LLP
Aug
17
2017
The TSCA Inventory Reset Begins: Toxic Substances Control Act Beveridge & Diamond PC
Aug
17
2017
Nanoscale Materials Reporting Rule Effective August 14; EPA Issues New Guidance Keller and Heckman LLP
Aug
17
2017
CFIA Launches DNA-based Projects to Boost Fruit Plant Trade Keller and Heckman LLP
Aug
17
2017
The Not-So-Secret Recipe: How Restaurants Can Protect Their Trade Secrets Ogletree, Deakins, Nash, Smoak & Stewart, P.C.
Aug
16
2017
Federal Court Dismisses Employer’s Claims For Indemnification and Contribution Against Drug Testing Vendor After False Positive Drug Test Result Jackson Lewis P.C.
Aug
16
2017
Putative Class Complains that Annie’s “Strawberry Fruit Snacks” Lack Strawberries Proskauer Rose LLP
Aug
16
2017
FDA Clarifies Sanitary Transportation Rule Waiver for Retail Food Establishments Keller and Heckman LLP
Aug
16
2017
340B Covered Entities Beware: CMS Proposes Drastic Drug Reimbursement Rate Cuts Polsinelli PC
Aug
16
2017
Alaska’s Telemedicine Business Registry: What You Need to Know Foley & Lardner LLP
Aug
15
2017
Medical Marijuana Users Can Sue Their Employers Murtha Cullina
Aug
15
2017
Considerations for Developing a Global Patent Term Extension Strategy Sterne, Kessler, Goldstein & Fox P.L.L.C.
Aug
15
2017
European Commission Outlines Possible New Approach to Regulating Printed FCMs Keller and Heckman LLP
Aug
15
2017
Patent Term Extension Considerations for BioPharma Patents Sterne, Kessler, Goldstein & Fox P.L.L.C.
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins